Serum muscle enzyme levels are usually elevated in patients with untreated polymyositis and dermatomyositis. Creatine kinase is the muscle enzyme most often used to diagnose inflammatory myopathies. Seven patients with dermatomyositis and normal creatine kinase levels are described. Five of the seven patients had either an associated malignancy or severe interstitial lung disease. The one-year survival of the six patients followed for that length of time was 33 percent. A lack of creatine kinase elevation in patients with dermatomyositis is a poor prognostic sign.
Polymyositis
and derrnatomyositis are inflammatory myopathies that commonly are associated with elevation of serum muscle enzyme levels. Creatine kinase is the muscle enzyme most widely used to diagnose polymyositis/dermatomyositis and to follow response to therapy [i-3] . Although most patients with polymyositis/dermatomyositis present with increased creatine kinase levels, reported series include some patients with normal creatine kinase levels at presentation [ 1, 2] . The course of this set of patients has not been addressed in the literature. After reviewing the records of all adults with polymyositis/dermatomyositis seen at the University of Michigan since 1979, it became apparent that a normal creetine kinase level at the time of diagnosis was associated with a poor prognosis. Of 38 patients reviewed, seven were found with normal creatine kinase levels and are the subject of this report (Table I) . CASE REPORTS Patient 1. A 69-year-old white woman was admitted to the University of Michigan Medical Center in October 1980, because of a rash of six months' duration and increasing proximal muscle weakness of two months' duration. On admission she had erythema with telangiectasias over her face, posterior neck, anterior chest, and dorsum of hands. Proximal muscle strength was 3/5 with normal distal muscle strength. Laboratory data included creatine kinase 71 IU/liter (normal 30 to 225 IWliter), aldolase 12 units/ml (normal 3 to 11 units/ml), serum. glutamic oxaloacetic transaminase 25 IU/liter (normal 2 to 35 Ill/liter), lactic dehydrogenase 267 Ill/liter (normal 60 to 200 IU/liter), rheumatoid factor 1:320, and no demonstrable antinuclear antibody. Electromyographic results were interpreted as an inflammatory myopathy. Biopsy of the right deltoid muscle showed a perivascular lymphocytic infiltrate and degenerative fibers. An evaluation for possible malignancy included chest radiography, barium enema, upper gastrointestinal series, intravenous pyelography, and mammography, all of which showed negative results. Therapy with prednisone 60 mg every day was begun with improvement in strength. In January 1981, axillary and supraclavicular adenopathy developed. Biopsy revealed metastatic adenocarcinoma of unknown primary. She died three months later. . A 78year-old white man was admitted in April 1984, with a five-month history of an erythematous rash and a two-month history of proximal arm and leg weakness. On examination he was seen to have erythema of the face and chest, Gottron's papules, and erythematous plaques on the knees and buttocks. Muscle strength was 415 proximally and 515 distally. An enlarged prostate with a nodule was found. Laboratory data included creatine kinase 177 IU/ liter, aldolase 5 units/ml, serum glutamic oxaloacetic transaminase 31 IU/liter, lactic dehydrogenase 234 IU/liter, and acid phosphatase 1.24 IWliter (normal 0 to 0.80 IU/ liter). Results of electromyography were interpreted as a moderately severe inflammatory myopathy. Biopsy of the left biceps revealed only mild nonspecific changes with a few moth-eaten and granular fibers and two ragged red fibers, Further evaluation of the prostate found transitional cell carcinoma metastatic to inguinal lymph nodes. The patient declined therapy for the metastatic carcinoma. He was treated with prednisone 15 mg three times a day and currently takes 5 mg every day with improvement but not full strength.
COMMENTS
Dermatomyositis is classified as "definite" when the characteristic skin rash is present in addition to at least three of the following: (1) proximal muscle weakness, (2) elevation of levels of serum muscle enzymes, especially creatine kinase, (3) electromyographic findings of inflammatory myopathy, and (4) positive findings on muscle biopsy. The diagnosis is "probable" when two criteria are met in addition to the rash [I] . Four of our patients met criteria for "definite dermatomyositis" and the other three met criteria for "probable dermatomyositis" before levels of serum enzymes were taken into account. If the elevations in levels of lactic dehydrogenase, serum glutamic oxaloacetic transaminase, and/or aldolase are considered as sufficient to satisfy the second criterion, all seven patients met criteria for "definite dermatomyositis."
Three patients had a malignancy associated with dermatomyositis and two others had severe interstitial lung disease in addition to skin and muscle involvement. Four of the seven patients died a mean of nine months from the onset of weakness (range four to 15 months), and a mean of seven months after diagnosis (range two to 12 months). A fifth patient has me&static cancer and thus far has survived seven months from the onset of weakness and five months from diagnosis. The one-year survival for the six patients followed for at least that length of time was 33 percent. This survival is dramatically lower than the 75 to 90 percent one-year survival reported in two large series of polymyositis and dermatomyositis [2, 4] and the 100 percent one-year survival of the remainder of the patients with polymyositis/dermatomyositis followed here.
The association between myositis and malignancy is controversial. The strongest association is that reported between malignancy and dermatomyositis. A recent review of the reported series of patients with polymyositis and dermatomyositis concluded that approximately onefourth of patients with dermatomyositis also had a malignancy, but the two were concurent in only one third of those cases [6] . In our series, three of the seven cases of dermatomyositis with normal creatine kinase levels were associated with malignancy. The cancer was apparent in only one of the patients when dermatomyositis was diagnosed. This association with malignancy is higher than would be expected from the literature. However, it is possible this finding is an artifact of our small sample size.
Interstitial lung disease is increasingly being recognized as a feature of polymyositis/dermatomyositis. Such pulmonary involvement has been detected radiographically in 5 to IO percent of patients in some series [6-81. Of the 65 cases reported in the English literature, about half have been associated with polymyositis and half with dermatomyositis [8] . The finding that two of seven patients with dermatomyositis and normal creatine kinase levels had severe, progressive interstitial lung disease strongly suggests that patients with normal creatine kinase levels are at risk for pulmonary manifestations of dermatomyositis.
Conditions that cause an abnormally low serum cretine kinase level, or that prevent an expected rise in creatine kinase level, are not well defined. Wei et al [9] found a lower mean creatine kinase level in patients with connective tissue disease than in a control population, but the mechanism for this observation was not reported. Low creatine kinase level has been found in some patients with liver diseases, including carcinoma metastatic to the liver [lo] , alcoholic liver disease [ 111, and viral hepatitis [ 121. It has also been reported in patients being treated with steroids [ 131 and cancer chemotherapy [ 141. We do not have a unifying explanation for the lack of creatine kinase elevation in the seven cases reported here. None of the patients were cachectic or immobile. Three of the patients (Patients 3, 4, and 5) had follow-up creatine kinase levels below the normal range while under treatment, which might suggest the lower average creatine kinase level found in patients with connective tissue disease combined with myositis resulted in normal creatine kinase levels in some patients. These three patients were treated with steroids, which is another possible explanation for the subnormal creatine kinase level, as just noted [13] , although the other four patients also received steroids.
These seven cases demonstrate the poor outcome of dermatomyositis without creatine kinase elevation. A normal creatine kinase level should not stop physicians from pursuing a diagnosis of inflammatory myopathy when there is strong clinical suspicion. If the diagnosis is ultimately made using other criteria, close follow-up for malignancy and interstitial lung disease is indicated.
